Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, today announced the launch of Cyto-Mine® Chroma and the opening of its Early Access Program at SLAS2025 International Conference and Exhibition in San Diego.

Experts applaud Amylyx for keeping its promise to withdraw ALS drug Relyvrio after trial failure

When Amylyx brought its ALS drug before the FDA in 2022, the biotech faced questions about what it would do if a crucial Phase 3

April 5, 2024

Want To Work in Psychedelics? The Industry Needs More Trial Screeners. | Psychedelic Invest

Psychedelic clinical studies have become a cornerstone in the evolving landscape of mental health treatment. With conditions like depression, PTSD, and anxiety reaching alarming prevalence,

August 14, 2024

Physician buy-in will make or break VC firm General Catalyst’s bold hospital deal

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.